Eli Lilly gets FDA approval for new migraine drug

Eli Lilly and Company (LLY) is up 0.1% Friday morning. The company announced the U.S. Food and Drug Administration approved its new migraine drug Emgality. The drug is expected to sell for $575 a month, in-line with two other new drugs that are on the market.

Eli Lilly and Company (LLY) is a drug manufacturer.

Lowe's Companies, Inc. (LOW) and The Boeing Company (BA) top the list of other companies with positive news today, while Tesla, Inc. (TSLA) and Applied Optoelectronics, Inc. (AAOI) top the list of companies with negative news.